Remove 2010 Remove Clinical Trials Remove Safety
article thumbnail

Project CBD Responds to the FDA’s 2023 Statement on CBD

Project CBD

It’s worth noting that cannabidiol (CBD), as a whole plant option or derivative has been available since 2010, and millions of people have used CBD products without apparent harm. A clinical trial by ValidCare assessing CBD’s impact on human liver function has given the compound a clean bill of health.

CBD 130
article thumbnail

Pharmadrug Announces Positive Research Results of Cepharanthine to Treat Multiple Cancers

Cannabis Law Report

Cepharanthine is on its way to establishing itself as a once per day, oral anti-cancer therapeutic with a well-established safety profile which will pave the way for an expedited clinical development pathway and future partnering opportunities with pharmaceutical companies. Epub 2010 Dec 17. ” Next Steps. 647) 202-1824.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.

article thumbnail

GOP Pennsylvania Lawmaker Files Psilocybin Research Bill For Veterans And First Responders

Cannabis Law Report

Indeed, studies conducted by world renowned medical institutions indicate that psilocybin has shown efficacy, tolerability, and safety in the treatment of conditions including but not limited to addiction, depression, anxiety disorders, and end-of-life psychological distress. Please join us in cosponsoring this legislation, thank you.

Therapy 52
article thumbnail

New Study: Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013–2017 Traffic Safety Culture Index

Cannabis Law Report

The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use. Because THC presence is an imperfect proxy for impairment [ 10 ], driving data may be limited in clarifying what traffic safety risks, if any, are associated with permissive marijuana policies.

Policy 45
article thumbnail

A New Treatment: CBD Oil For Autism?

Puff Puff Post

With so many people affected by autism and incidence rates having increased by 119% between the years 2000 to 2010, it has gained the status of the quickest-growing developmental disability. The study also concludes that more clinical trials are required to take place before an accurate assessment on the use of cbd oil for autism can be made.

article thumbnail

New PTSD study finds cannabis safe, but not as effective as assumed

SpeedWeed

for the production of cannabis used in federally-regulated clinical trials. Early on in the study, criticism over the poor quality and low potency of the NIDA-supplied cannabis prompted Johns Hopkins University to withdraw from the multi-year clinical trials. He has covered the legal cannabis industry since 2010.